Can freezing nerves during heart surgery slash pain and opioid use?
NCT ID NCT05859061
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This pilot trial tests a technique called cryoanalgesia, which uses extreme cold to temporarily freeze nerves in the chest during heart surgery. The goal is to block pain signals, potentially reducing the need for opioid painkillers and improving recovery. The study enrolls adults scheduled for coronary bypass or single valve surgery through a breastbone incision.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cryoanalgesia using the cryoICE system with CryoSphere probe to freeze intercostal nerves
- What this could lead to
- If it works, this could offer a drug-free way to manage pain after heart surgery, reducing reliance on opioids.
- What could go wrong
- This is a small pilot study with only 32 participants, so results may not apply broadly. Nerve freezing carries risks like temporary numbness or nerve damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
32 people
The number who actually took part.
- Started
-
Apr 2023
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Scheduled for elective CABG (coronary artery bypass graft) or single valve surgery via median sternotomy * Reasonable expectation to be extubated within 24 hours postop Exclusion Criteria: * Prior history of surgery to the thorax (sternotomy, thoracotomy, thoracoscopy) * Hemisternotomy approach * History of cold urticaria, cryoglobulinemia, Raynaud's disease, or diabetic neuropathy * Preoperative use of opioids * History of chronic pain or associated syndromes * Concurrent Cox maze procedure * Need for post-bypass mechanical circulatory support (ECMO, IABP) or open chest * Women who are pregnant or breastfeeding * Patients who are unable to consent for themselves
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart bypass surgeons test which vein layout keeps grafts open
- Three ways to block hernia surgery pain go head to head
- A soft patch that watches your heart beat in real time
- Zapping the ear: a new way to stop Post-Surgery heart rhythm problems?
- Squeeze a ball, lower your blood pressure? heart trial puts handgrip exercise to the test
- New heart scan aims to spot hidden plaque before it strikes